MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Phenytoin sodium

CAS No. : 630-93-3

MCE 站：Phenytoin sodium

产品活性：Phenytoin sodium (5,5-Diphenylhydantoin sodium salt) 是一种有效的电压门控 Na⁺ 通道 (VGSCs) 阻滞剂。Phenytoin 具有抗癫痫活性，也可减少小鼠乳腺肿瘤的生长和转移。

研究领域：Membrane Transporter/Ion Channel  |  Anti-infection

作用靶点：Sodium Channel  |  Virus Protease

In Vitro: Phenytoin sodium is an antiepileptic drug. It is useful to treat partial seizures and generalized tonic-clonic seizures but not primary generalized seizures such as absence seizures or myoclonic seizures. Phenytoin is believed to protect against seizures by causing voltage-dependent block of voltage-gated sodium channels.
Phenytoin has low affinity for resting sodium channels at hyperpolarized membrane potentials.
When neurons are depolarized and the channels transition into the open and inactivated states, greater binding and block occur. The inhibitory potency is strongly use dependent, so that block accumulates with prolonged or repetitive activation, such as occurs during a seizure discharge. The blocking of sodium channels by phenytoin is of slow onset. The time course of fast sodium currents is therefore not altered in the presence of the drug and action potentials evoked by synaptic depolarizations of ordinary duration are not blocked. Thus phenytoin is able to selectively inhibit pathological hyperexcitability in epilepsy without unduly impairing ongoing activity. Phenytoin also blocks persistent sodium current and this may be of particular importance in seizure control. Phenytoin is a class 1b antiarrhythmic.

In Vivo: Phenytoin sodium (5,5-Diphenylhydantoin sodium salt; 60 mg/kg; daily; 28 days ) reduces tumour growth in six week-old female Rag2^-/- Il2rg^-/- mice with MDA-MB-231 cells.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Anti-Infection Compound Library  |  Membrane Transporter/Ion Channel Compound Library  |  FDA-Approved Drug Library  |  Antiviral Compound Library  |  CNS-Penetrant Compound Library  |  Drug Repurposing Compound Library  |  Anti-COVID-19 Compound Library  |  NMPA-Approved Drug Library  |  Orally Active Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Neuroprotective Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  4-Phenylbutyric acid  |  Glycyrrhizic acid  |  Aspirin  |  Ebselen  |  Dynasore  |  EIPA  |  Amiloride hydrochloride  |  Artesunate  |  Monensin sodium salt  |  Brequinar  |  Carbamazepine  |  5-(N,N-Hexamethylene)-amiloride  |  PF429242 dihydrochloride  |  Riluzole  |  Carmofur  |  20(S)-Ginsenoside Rg3  |  Lidocaine  |  Amitriptyline hydrochloride  |  Cariporide  |  Lycorine hydrochloride  |  Hinokitiol  |  Lamotrigine  |  Ranolazine dihydrochloride  |  Flecainide acetate  |  NH125  |  Phenytoin  |  Probucol

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。